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Background: Colonisation with Burkholderia cepacia complex pathogens has been associated with accelerated decline in cystic fibrosis
(CF) patients. The two most common species among the CF community are Burkholderia cenocepacia and Burkholderia multivorans.
However, Burkholderia dolosa has recently been causing concern due to its transmissibility and virulence in CF patients.
Methods: We have compared the ability of five B. dolosa strains to invade lung epithelial cells in vitro with other members of the Bcc. The
bacterial epithelial cell interaction was visualised by transmission electron microscopy. We have also examined the ability of these strains to
form biofilms in vitro.
Results: We have found that members of this species can invade pulmonary epithelial cells in vitro as readily as those from B. cenocepacia
and B. multivorans. Confirmation of intracellular invasion was obtained by transmission electron microscopy. B. dolosa strains were readily
observed in membrane bound vesicles inside the lung epithelial cells. In addition, strains from this species were capable of forming strong
biofilms at a level comparable to the more clinically relevant species.
Conclusions: B. dolosa shows comparable virulence characteristics in vitro to the two most clinically relevant species indicating precautions
should be taken when this species is identified in the CF population.
© 2006 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Burkholderia cepacia complex; Burkholderia dolosa; Virulence; Biofilm; Invasion1. Introduction
Bacterial pathogens continue to contribute to the
morbidity and mortality in people with cystic fibrosis (CF).
Chronic respiratory tract infections are caused by several
bacterial species including Pseudomonas aeruginosa, Staph-
ylococcus aureus, Burkholderia cepacia complex (Bcc) and
emerging pathogens such as Stenotrophomonas maltophilia,
MRSA, Achromobacter xylosoxidans and Klebsiella species
[1,2]. Bcc are a group of related species that are important⁎ Corresponding author. Tel.: +353 1 4042794; fax: +353 1 4042404.
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doi:10.1016/j.jcf.2006.05.007opportunistic pathogens in cystic fibrosis patients [3]. The
respiratory tract infections may persist for months or even
years and in certain patients can cause a life-threatening
pneumonia. Nine species have been identified to date, with
varying degrees of virulence in cystic fibrosis patients [4].
Two of these, Burkholderia cenocepacia and Burkholderia
multivorans, are the most clinically relevant as they are the
most predominant isolates recovered from CF patients and
the most virulent species. However, recently it has emerged
that virulence is not confined to these two species. In
particular Burkholderia dolosa, formerly B. cepacia geno-
movar VI, has been causing concern in terms of its virulence
and transmissibility. It is not very prevalent among CF
patients, it was reported that B. dolosa represented less thaned by Elsevier B.V. All rights reserved.
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However, it was the first Bcc species to be identified as being
involved in patient-to-patient transmission with the same
isolate being found in 36 patients [6–8]. Indeed, this species
accounted for 35% of Bcc infection at a single centre. In a
recent formal cohort study it was reported that there was an
accelerated decline in lung function in B. dolosa colonised
patients compared with B. multivorans colonised patients
and reduced survival in the B. dolosa cohort [8]. There were
five deaths recorded among the 31 B. dolosa patients, at least
one of these patients died as a result of cepacia syndrome.
Two in vitro virulence factors that are considered to
correlate with clinical virulence of Bcc species are invasion of
lung epithelial cells and biofilm formation [4], both of which
may contribute to their persistence in the cystic fibrosis lung.
The two most virulent species of B. cenocepacia and B.
multivorans strains invaded lung cells more readily than B.
cepacia, Burkholderia stabilis and Burkholderia vietnamien-
sis in an in vitromodel of invasion [9]. In addition a study on
the same five Bcc species showed that strains from these two
more virulent species were capable of greater biofilm
formation in vitro compared to the other three species [10].
Bcc biofilms have been found to have increased resistance to
ciprofloxacin and ceftazidime [11]. However, B. dolosa was
not evaluated in these studies. We have therefore investigated
five B. dolosa strains including those from the Bcc
experimental strain panel [12] and compared them with
other species within the Bcc to compare the in vitro virulence
of this species with other members of the complex.
2. Materials and methods
2.1. Bacterial strains and growth
The Bcc strains used in this study (Table 1) were all from
the panel of Bcc strains identified by the International B.
cepacia working group [12,13]. All Bcc strains, except those
of B. dolosa, were obtained from Professor Peter Vandamme,
Laboratory for Microbiology, Ghent University, Ghent,
Belgium. The B. dolosa strains were purchased from
BCCM/LMG Bacteria Collection (Ghent University,
Ghent, Belgium). They were routinely grown in Luria–
Bertani (LB) agar or LB broth at 37 °C. Growth curves were
determined by incubating bacteria in LB (pH 7.0) at 37 °C
and 200 rpm. Aliquots were removed at specific time
intervals and optical density (OD) measured at 600 nm.
Serial dilutions were made and aliquots (50 μl) plated onto
LB agar plates. Plates were incubated at 37 °C for 48 h and
CFU/ml determined for each strain.
2.2. Cell lines
The bronchial epithelial cells 16HBE14o- cells (passages
2.48 to 2.68) were kindly provided by Dr Dieter Gruenert
and were maintained in collagen coated flasks in DMEM
supplemented with 10% FBS.2.3. Antibiotic susceptibility of Bcc strains.
The minimum inhibitory concentration (MIC) of each
strain was determined for amikacin and ceftazidime as
previously described [14,15]. The minimum bactericidal
concentration (MBC) was carried out by growing each strain
in LB to an OD600 nm of 0.6 and inoculating 20 μl of each
culture into a 96-well plate containing serial dilutions of each
antibiotic resuspended in 180 μl of LB broth. Each plate was
incubated at 37 °C for 24 h and the plate was read at an OD
of 600 nm. In addition, 50 μl of each well was also spread on
LB agar and incubated for 48 h to determine the MBC of
each antibiotic. The susceptibility of strains to the antibiotic
concentrations (1 mg/ml each of amikacin and ceftazidime)
used in the invasion assay over a 2-h incubation period was
also tested by plating strains that had been incubated for 2 h
with antibiotic on LB agar and incubated for 48 h.
2.4. Invasion of epithelial cells by Bcc
Invasion studies were carried out on 16HBE14o-
epithelial cells using an adaptation of the method by Martin
and Mohr [16]. The cells were seeded on 24-well plates
(4×105 cells/well), cultured for 24 h at 37 °C, 5% CO2, and
incubated with Bcc strains at a multiplicity of infection of 50
bacterial cells per epithelial cell (MOI of 50 :1) for 2 h.
Escherichia coli NCIB9485 was used as a negative control.
The cells were washed three times with PBS and treated with
amikacin/ceftazidime (1 mg/ml, each) for 2 h to kill any
remaining extracellular bacteria. Intracellular bacteria were
released by lysis with 0.5% Triton X-100, 50 mM EDTA.
Invasion was quantitated by serial dilution and plating onto
LB agar. The % invasion was determined as follows:
ðCFU=ml recovered from lysed cells=CFU applied to cellsÞ
 100
Prior to lysis, the medium was removed and cultured in LB
to ensure that no extracellular bacteria survived the antibiotic
treatment.2.5. Examination of invasion by transmission electron
microscopy (TEM)
16 HBE14o- cells were grown on 6-well plates overnight
prior to incubation with Bcc strains, E. coli NCIB9485 or on
medium alone for 2 h. Cells were washed with PBS and fixed
with 2.5% (v/v) glutaraldehyde for 24 h at 4 °C. Cells were
scrapped from the wells, centrifuged and the pellet post-fixed
in 1% (w/v) osmium tetroxide in phosphate-buffered saline.
Alternatively, the cells were fixed in situ. Each sample was
dehydrated through ascending concentrations of ethanol,
70%, 90%, and 100%. Cells were impregnated with Epon
resin and embedded at 60 °C overnight. Ultra-thin sections
cut with a diamond knife were stained with toluidine blue
and visualized by light microscopy or stained with uranyl
Table 1
Strains belonging to the B. cepacia complex experimental panel used in this
study and their doubling times
Species/Strain Sourcea Doubling time (h)b
B. cepacia
ATCC24516 Onion 1.3
ATCC17759 Soil 1.7
B. multivorans
LMG13010 CF 2.9
C1962 Abscess 1.3
ATCC17616 soil 2.0
B. cenocepacia
J2315 CF 2.1
BC7 CF 1.9
C1394 CF 2.0
ATCC17765 Urinary tract infection 3.1
B. stabilis
LMG14924 CF 2.3
C7322 CF 2.1
B. vietnamiensis
PC259 CF 2.1
LMG10929 Rice 2.4
B. dolosa
LMG18941 CF 2.2
LMG21443 Root nodule 2.1
LMG18943 CF (AU0645) 1.7
LMG18944 CF 1.2
LMG21820 CF 1.3
a Coeyne et al. [12] and Mahenthiralingam et al. [13].
b Doubling time in LB at 37 °C at 200 rpm.
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transmission electron microscope using an accelerating
voltage of 120 kV and an objective aperture of 10 μ.
2.6. Quantitation of biofilm formation
Biofilm formation was examined by determining the
ability of Bcc strains to form biofilms in microtitre plates
[17]. Briefly, LB (100 μl/well) was inoculated with the mid-
log phase (OD600∼0.6) individual strains at 1×106 or
1×107 CFU/ml) in quadruplicate. After inoculation, the
plates were incubated at 37 °C for the specified times, rinsed
thoroughly with water to remove unadhered bacteria and air-
dried. Crystal violet (1%) was added to each of the wells and
the plates incubated at ambient temperature for 30 min. The
plates were then rinsed again thoroughly and the dye
dissolved with 95% ethanol containing 0.05% Triton X. The
solubilised crystal violet (100 μl) was transferred to a new
polystyrene microtitre plate and absorbance determined at
595 nm (Tecan Plate reader, Alpha technologies). Biofilm
formation was defined as those wells that had A590>0.05.
2.7. Statistical analysis
Comparison of invasiveness of the strains against the
negative control was carried out by Dunn's multiple
comparison test. P values<0.05 were deemed to be
significant in all comparisons.
3. Results
3.1. Doubling times of the Bcc strains
The doubling times of the strains ranged from 70 min to
186 min. Of the 18 isolates, 11 had doubling times of 1.5 to
2.5 h when grown in LB with shaking (Table 1). These
included strains from all six species examined.
3.2. Invasion of 16HBE14o-cells by Bcc strains
The in vitro invasion assay depends on the killing of all
extracellular bacteria prior to cell lysis. We ensured that all
strains used in the study were susceptible to amikacin and
ceftazidime (1 mg/ml each). All strains examined in this
study had microbial biocidal concentrations (MBCs) of
512 μg/ml or less for both amikacin and ceftazidime.
Therefore 1 mg/ml of each antibiotic was used in
combination for all strains. In addition, during the invasion
assay, the medium was removed from cells following the
combination antibiotic treatment, no bacteria of any strain
were detected after 48 h in culture, demonstrating that
extracellular bacteria did not survive the antibiotic treatment
under the conditions of the invasion assay.
We evaluated at least two strains from each of the species
listed below, for their potential to invade 16HBE14o- cells in
vitro (Fig. 1). Only five strains of the sixteen examined werefound to be significantly more invasive than E. coli using
multiple comparison analysis (Dunn's test, P<0.05). These
strains were members of B. cenocepacia (C1394 and BC7),
B. multivorans (LMG13010) and surprisingly, two B. dolosa
strains examined (LMG18943 and LMG18941). All strains
from B. cepacia, B. stabilis and B. vietnamiensis and the
remaining strains from B. multivorans (C1962) and B.
cenocepacia (ATCC17765) did not show significantly
different levels of invasion compared to the negative control.
Two additional strains from B. dolosa, LMG18944 and
LMG21443, showed levels of invasion comparable to B.
cenocepacia strain BC7, however, due to the variability in
invasion levels observed, they were not statistically more
invasive than E. coli using Dunn's test.
3.3. Analysis of intracellular bacteria by TEM
TEM analysis confirmed intracellular invasion of B.
dolosa strains, LMG18941 and LMG18943. Both strains
were also observed in membrane bound vesicles within the
cytoplasm of the epithelial cells (Fig. 2a–d). Large numbers
of both strains were also attached to the surface of the
16HBE14o- cells particularly at the junctions between cells
(Fig. 2a–d). The bacteria appeared to align parallel to the
epithelial membrane prior to invasion (Fig. 2b). In addition,
the epithelial cells appeared to extend cellular projections in
order to make contact with the pathogens (Fig. 2c). These
extensions were not observed in control cells (Fig. 2i). B.
cenocepacia strain, BC7, was also observed at the surface of
Fig. 1. Invasion of 16HBE14o-cells by B. cepacia complex strains compared to E. coli strain NCIB9485. Bars represent % invasion±standard error of three
independent assays. ⁎Statistically different from control strain (P<0.05), E. coli NCIB9485.
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2e–g). Evidence of vacuole formation around a number of
BC7 cells was also observed; bacteria are clearly seen within
a vesicle which is in the process of pinching off (Fig 2f).
These vesicles did not have the appearance of coated pits.
Although TEM is not quantitative, internalised bacteria were
more readily observed for both of the B. dolosa strains
compared with BC7. E. coli NCIB9485 were observed at a
distance from the epithelial membrane; however, they were
not attached to the surfaces of epithelial cells (Fig. 2h). In
addition, there was no evidence of intracellular invasion by
E. coli.
3.4. Biofilm formation by Bcc species
One of the main limitations in successful eradication of
Bcc is its ability to form biofilms. Therefore we wanted to
compare B. dolosa with other members of Bcc to examine if
it had a comparable potential for biofilm formation. Our data
confirmed that B. multivorans showed the greatest capacity
for biofilm formation, with two of the three species tested
showing strong biofilms at 48 h (Fig. 3a). One B. multivorans
strain, C1962 formed weaker biofilms, which just rose abovethe A590 threshold of 0.05 under these conditions. All strains
of B. cenocepacia, except ATCC17765, were also capable of
forming biofilms, with the ET12 strain BC7 forming the
strongest biofilms in this species. Overall, the OD values
obtained for B. cepacia, B. stabilis and B. vietnamiensiswere
less than 0.05 at 48 h and even at 72 h (data not shown)
indicating that these latter three species generally did not
form biofilms. Surprisingly, however, four of the five B.
dolosa strains tested were capable of forming strong biofilms
in 48 h which were comparable to those formed by both B.
multivorans and B. cenocepacia. The potential for B. dolosa
to form strong biofilms was further illustrated by the fact that
the same four strains formed biofilms within 48 h using an
inoculum of only 106 CFU/ml (Fig. 3b). The only other
strains capable of forming biofilms at this lower inoculum
were members of B. multivorans and B. cenocepacia (Fig.
3b). There was no correlation between growth rates of the
strains (Table 1) and their biofilm formation.
4. Discussion
B. dolosa is not very prevalent among CF patients;
however, it has previously been shown to be transmissible
Fig. 2. Transmission electron micrographs of 16HBE14o-cells following two hour incubation with B. dolosa strains LMG18941 (a and b); LMG18943 (c and d);
B. cenocepacia strain BC7 (e–g); E. coli strain NCIB9485 (h) or medium alone (i) at an MOI of 50 :1. Both B. dolosa strains are clearly visible intracellularly
(white arrows) and adjacent to the plasma membrane (dark arrows). Examples of epithelial cell projections are visible in (c). Vesicle formation was observed
around BC7 cells (f, white arrow), pinching off the vesicle indicated with black arrow. Extracellular BC7 cells indicated by black arrow (e); internalised BC7 cells
are indicated in (g) by white arrow. Bar=2 μm for all except (b): 1 μm and (h): 5 μm.
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Fig. 3. Biofilm formation by B. cepacia complex strains at different incubation times. Representative strains from six species were inoculated at 1×107 CFU/ml
(a) or 1×106 CFU/ml (b) and grown in 96-well plates for 24 h (black) and 48 h (grey bars) and the biofilms stained with crystal violet. Bars represent the mean
±standard error of three separate experiments.
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dolosa colonised patients showed an accelerated decline in
FEV1, and had a higher probability of dying within
18 months of the first Bcc positive culture than B.
multivorans colonised patients. We have shown that this
species has the potential both to invade pulmonary epithelial
cells and to form biofilms to a comparable extent as the two
species previously identified as most virulent, B. cenocepa-
cia and B. multivorans.
A correlation between invasion of pulmonary epithelial
cells, A549 by individual strains and an in vivo invasiveness
in a mouse model of B. cepacia complex lung infection has
been reported [9]. It was demonstrated that strains from B.
cenocepacia and B. multivorans were more invasive than
those of the other three species examined. Consistent with
that report, we have also found that these two species again
show more invasiveness than B. stabilis, B. cepacia and B.
vietnamiensis in 16HBE14o- cells. However, unexpectedly,
B. dolosa invasiveness was comparable to that of B.
cenocepacia and B. multivorans. The variability in invasion
observed for each strain has been previously reported [9] and
is inherent in this type of assay. The order of invasiveness of
the B. cenocepacia strains in 16HBE14o- correlates well
with those reported previously, with C1394 being most
invasive, BC7 next and ATCC 17765 showing poor
invasion. In addition to LMG18941 and LMG 18943, two
other strains of B. dolosa showed a trend towards
invasiveness; however, this was not statistically significant
by Dunn's test due to the inherent variability in the assay.
Confirmation of intracellular invasion was obtained by
TEM analysis. Both B. dolosa strains examined were readily
observed in membrane bound vesicles of the 16HBE14o-
cells. It has been previously shown that a strain of B. dolosa
invaded macrophages and remained viable and motile for
5 days [19]. However, no comparison of the extent of
invasion of B. dolosa strains relative to other species has
been published to date. Furthermore, this is the first evidence
of B. dolosa inside lung epithelial cells.
Four of the five B. dolosa strains formed biofilms,
including LMG 21443, which is a root nodule isolate. The
extent of biofilm formation was comparable with those of
B. multivorans and B. cenocepacia. The ability to form
biofilms was not correlated with growth rate, since the B.
dolosa strain that did not form biofilms (LMG21820) had
a doubling time of 1.3 h, while the four that did form
biofilms had doubling times of 1.2 to 2.2 h. Vermis et al.
have previously demonstrated that B. dolosa was most
resistant to antimicrobial agents in a study of 142 isolates
from all nine species [18]. In addition, we and others have
shown that Bcc biofilms showed increased resistance to
antibiotics [11,20], suggesting that biofilm formation will
reduce the efficacy of antibiotic treatment in patients. This
ability to form strong biofilms will impact further on the
antimicrobial resistance of this species and will make them
more difficult to eradicate. While no clear correlation was
observed between biofilm formation and the virulence ofrespiratory infection in Bcc colonised patients, one study
of 21 patients has shown that all the patients that died
during the study were harbouring biofilm forming strains
[21]. Furthermore, the three patients that succumbed to
cepacia syndrome all harboured strains which formed
moderate to thick biofilms.
The factors that lead to the decline of Bcc infected
patients is multifactorial, however, our findings that B.
dolosa has comparable biofilm forming potential and
comparable invasiveness in 16HBE14o-cells to both B.
cenocepacia and B. multivorans, suggest that these traits in
B. dolosa may translate to clinical virulence in certain
patients. Although B. dolosa is not prevalent among the CF
population, it has been found to be quite virulent in patients
that it colonises. While B. cenocepacia and B. multivorans
remain the most clinically relevant species, the potential for
virulence and the precautions in terms of patient segregation
should not be limited to these two species.
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